U.S. eClinical Solutions Market
U.S eClinical Solutions Market Research 2022 Report: Examines the $1.3+ Million Industry
12 avr. 2022 06h08 HE | Research and Markets
Dublin, April 12, 2022 (GLOBE NEWSWIRE) -- The "eClinical Solutions Market Research Report by Product, by Delivery Mode, by Development Phase, by End-user, by State - United States Forecast to 2027...
Global Virtual Clinical Trials Market
The Global Virtual Clinical Trials Market Will Grow to USD 8,555+ Million by 2027, at a CAGR of 22.28%
11 avr. 2022 07h43 HE | Research and Markets
Dublin, April 11, 2022 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trials Market Research Report by Study Design, by Implication, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19"...
Rubius_Logo.jpg
Rubius Therapeutics to Host Investor Webcast to Discuss Updated Clinical Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2 Clinical Trial of RTX-240 in Patients with Advanced Solid Tumors on April 8, 2022, at 1:15 PM ET
07 avr. 2022 08h00 HE | Rubius Therapeutics
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create...
Wave Logo with Swoosh_R.jpg
Wave Life Sciences Announces Positive Update to Ongoing Phase 1b/2a FOCUS-C9 Study Driven by Potent, Durable Reductions of Poly(GP) with Low, Single Doses of WVE-004
04 avr. 2022 07h30 HE | Wave Life Sciences USA, Inc.
Reductions in poly(GP), a key disease biomarker indicating target engagement, observed across all treatment groups after single doses Extending dose observation period from three months (day 85) to...
Black patients more
Black patients more likely to be excluded from pancreatic cancer clinical trials
29 mars 2022 10h32 HE | VCU Massey Cancer Center
RICHMOND, Va., March 29, 2022 (GLOBE NEWSWIRE) -- Clinical trials are responsible for determining the safety and efficacy of drugs, and lead to virtually all standards of cancer care in the U.S....
Featured Image for Triall
Triall Partners With Crucial Data Solutions to Realize the World's First End-to-End eClinical Platform Powered by Blockchain
24 mars 2022 07h00 HE | Triall (986799)
MAARSSEN, Netherlands, March 24, 2022 (GLOBE NEWSWIRE) -- Triall, a tokenized platform for blockchain-enabled clinical trial technology, has partnered with Crucial Data Solutions (CDS), an eClinical...
Featured Image for OcyonBio
OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Biosimilar Product
23 mars 2022 12h00 HE | OcyonBio (ocyonbio.com)
AGUADILLA, Puerto Rico, March 23, 2022 (GLOBE NEWSWIRE) -- Biosimilar Solutions, Inc. announces it has started its registrational clinical trials for BSC1020®, a recombinant filgrastim product...
Axiom_20Years_Updated logo.jpg
Axiom Exhibiting at Outsourcing in Clinical Trials Southeast 2022
23 mars 2022 09h44 HE | Axiom Real-Time Metrics Inc
TORONTO, March 23, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
Adaptive-Research-Logo_PMS187-423[3].png
Adaptive Research Announces a Collaboration with American Molecular Imaging to Add Nearly 500 Physicians to its Growing Research Network
15 mars 2022 16h44 HE | Adaptive Research Inc
SAN FRANCISCO, March 15, 2022 (GLOBE NEWSWIRE) -- Adaptive Research Inc., an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community...
Adaptive-Research-Logo_PMS187-423[3].png
Adaptive Research Expands Operations Team to Position the Company for Growth in 2022
14 mars 2022 16h20 HE | Adaptive Research Inc
SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) -- Adaptive Research, an integrated clinical trial site organization with a unique purpose to democratize clinical trials by integrating community...